Automate Your Wheel Strategy on CYRX
With Tiblio's Option Bot, you can configure your own wheel strategy including CYRX - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.
Start Your Free Trial NowKey Metrics & Ratings
- symbol CYRX
- Rev/Share 4.3012
- Book/Share 7.9847
- PB 0.913
- Debt/Equity 0.6085
- CurrentRatio 5.5555
- ROIC -0.1905
- MktCap 365500188.0
- FreeCF/Share -0.6885
- PFCF -10.629
- PE -3.3764
- Debt/Assets 0.3467
- DivYield 0
- ROE -0.2664
- Rating B-
- Score 3
- Recommendation Neutral
- P/E Score 1
- DCF Score 5
- P/B Score 5
- D/E Score 2
Recent Analyst Ratings
| Type | Ticker | Analyst Firm | Previous Rating | Current Rating | Previous Price Target | Current Price Target | Date |
|---|---|---|---|---|---|---|---|
| Upgrade | CYRX | UBS | Neutral | Buy | -- | $10 | March 24, 2025 |
| Initiation | CYRX | Guggenheim | -- | Buy | -- | $11 | Dec. 19, 2024 |
News
CryoPort (CYRX) Upgraded to Buy: Here's What You Should Know
Published: June 27, 2025 by: Zacks Investment Research
Sentiment: Positive
CryoPort (CYRX) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Read More
Wall Street Analysts Believe CryoPort (CYRX) Could Rally 81.43%: Here's is How to Trade
Published: May 28, 2025 by: Zacks Investment Research
Sentiment: Positive
The average of price targets set by Wall Street analysts indicates a potential upside of 81.4% in CryoPort (CYRX). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.
Read More
Does CryoPort (CYRX) Have the Potential to Rally 54.74% as Wall Street Analysts Expect?
Published: May 12, 2025 by: Zacks Investment Research
Sentiment: Positive
The mean of analysts' price targets for CryoPort (CYRX) points to a 54.7% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.
Read More
Cryoport, Inc. (CYRX) Q1 2025 Earnings Call Transcript
Published: May 07, 2025 by: Seeking Alpha
Sentiment: Neutral
Cryoport, Inc. (NASDAQ:CYRX ) Q1 2025 Results Conference Call May 7, 2025 5:00 PM ET Company Participants Jerrell Shelton - CEO Robert Stefanovich - CFO Mark Sawicki - Chief Scientific Officer Thomas Heinzen - VP IR and Corporate Development Todd Fromer - IR, KCSA Strategic Communications Conference Call Participants Kyle Crews - UBS Richard Baldry - ROTH Capital David Larsen - BTIG Subbu Nambi - Guggenheim Securities Matt Stanton - Jefferies Anna Snopkowski - KeyBanc Operator Good afternoon, and welcome to Cryoport's First Quarter 2025 Earnings Call. All participants will start in a listen-only mode.
Read More
CryoPort, Inc. (CYRX) Reports Q1 Loss, Tops Revenue Estimates
Published: May 07, 2025 by: Zacks Investment Research
Sentiment: Negative
CryoPort, Inc. (CYRX) came out with a quarterly loss of $0.22 per share versus the Zacks Consensus Estimate of a loss of $0.23. This compares to loss of $0.43 per share a year ago.
Read More
CryoPort, Inc. (CYRX) Expected to Beat Earnings Estimates: Should You Buy?
Published: April 30, 2025 by: Zacks Investment Research
Sentiment: Positive
CryoPort (CYRX) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Read More
DHL Group acquires CRYOPDP from Cryoport to strengthen "DHL Health Logistics"
Published: March 31, 2025 by: PRNewsWire
Sentiment: Neutral
DHL to acquire 100% of CRYOPDP, a leading specialty courier providing logistics services for clinical trials, biopharma, and cell & gene therapies. This acquisition enhances DHL's capabilities in specialty pharma logistics and supports Group's 2030 strategy to become a leader in life science and healthcare logistics.
Read More
Cryoport, Inc. (CYRX) Q4 2024 Earnings Call Transcript
Published: March 04, 2025 by: Seeking Alpha
Sentiment: Neutral
Start Time: 17:00 January 1, 0000 5:41 PM ET Cryoport, Inc. (NASDAQ:CYRX ) Q4 2024 Earnings Conference Call March 04, 2025, 17:00 PM ET Company Participants Jerrell Shelton - CEO Robert Stefanovich - CFO Mark Sawicki - Chief Scientific Officer Thomas Heinzen - VP IR and Corporate Development Todd Fromer - IR, KCSA Strategic Communications Conference Call Participants Anna Snopkowski - KeyBanc Capital Markets Puneet Souda - Leerink Partners David Saxon - Needham Subbu Nambi - Guggenheim David Larson - BTIG Richard Baldry - Roth Capital Kyle Crews - UBS Matt Stanton - Jefferies Operator Good afternoon, and welcome to …
Read More
CryoPort, Inc. (CYRX) Reports Q4 Loss, Tops Revenue Estimates
Published: March 04, 2025 by: Zacks Investment Research
Sentiment: Negative
CryoPort, Inc. (CYRX) came out with a quarterly loss of $0.42 per share versus the Zacks Consensus Estimate of a loss of $0.33. This compares to loss of $0.51 per share a year ago.
Read More
About Cryoport, Inc. (CYRX)
- IPO Date 2005-08-22
- Website https://www.cryoport.com
- Industry Integrated Freight & Logistics
- CEO Jerrell W. Shelton
- Employees 1090